Rapamycin For Longevity With Matt Kaeberlein Robert Lufkin Md In the latest episode of longevity by design, our co hosts, dr. gil blander and ashley reaver, are joined by dr. matt kaeberlein, professor at the department of laboratory medicine and pathology at the university of washington. In the latest episode of longevity by design, our co hosts, dr. gil blander and ashley reaver, are joined by dr. matt kaeberlein, professor at the department of laboratory medicine and pathology at the university of washington.
A Longevity Expert S Reality Check What Actually Works And What Doesn This video is a great talk from dr. matt kaeberlein at raadfest 2025, which took place a few weeks ago in las vegas. the first part of matt’s presentation is a great overview of the dog aging project and why companion animals (dogs) are great organisms to study the biology of aging. Listen to this episode from longevity by design on spotify. recent studies highlight the role of specific longevity agents like rapamycin in slowing the aging process in animal models. Founded by dr. matt kaeberlein, a passionate advocate for aging research, this project harnesses the power of citizen science to collect vast amounts of data from dog owners across the united states. This episode offers a grounded look at the science behind longevity interventions and what responsible progress in aging research actually looks like.
Dr Matt Kaeberlein Anti Aging Longevity Expert Biography 0 Founded by dr. matt kaeberlein, a passionate advocate for aging research, this project harnesses the power of citizen science to collect vast amounts of data from dog owners across the united states. This episode offers a grounded look at the science behind longevity interventions and what responsible progress in aging research actually looks like. The dog aging project is a long term biological study of aging in dogs, centered at the university of washington. [1] professors daniel promislow and matt kaeberlein are the co directors of the project. Dr. kaeberlein is a pioneer in the unique field of canine aging, identifying the genetic, environmental, and lifestyle factors that impact dog longevity—and, with that, how it can impact. Dr. matt kaeberlein, a leading researcher in aging, explores the dog aging project's innovative approach to understanding canine longevity. he discusses the study's design and its potential implications for human aging.
Dr Matt Kaeberlein Novel Research On Longevity Agents In Domestic Dogs The dog aging project is a long term biological study of aging in dogs, centered at the university of washington. [1] professors daniel promislow and matt kaeberlein are the co directors of the project. Dr. kaeberlein is a pioneer in the unique field of canine aging, identifying the genetic, environmental, and lifestyle factors that impact dog longevity—and, with that, how it can impact. Dr. matt kaeberlein, a leading researcher in aging, explores the dog aging project's innovative approach to understanding canine longevity. he discusses the study's design and its potential implications for human aging.
Comments are closed.